UK Ibrance Patient Program (IPP) Study

NCT03921866 · clinicaltrials.gov ↗

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

HR+/HER2- Locally Advanced, Metastatic Breast Cancer

Interventions

DRUG: Palbociclib

Sponsor

Pfizer